MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹381 Cr |
| Mar2024 | ₹314 Cr |
| Mar2023 | ₹266 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹236 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹381 Cr | 21.32 | |
| Mar2024 | ₹314 Cr | 17.80 | |
| Mar2023 | ₹266 Cr | 44.29 | |
| Mar2022 | ₹185 Cr | -21.77 | |
| Mar2021 | ₹236 Cr | - | |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,378.1 Cr | 2.5% | -7.6% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 2.5% |
-7.6% |
-24% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses